Cargando…
P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430743/ http://dx.doi.org/10.1097/01.HS9.0000846344.56300.e1 |
| _version_ | 1784779860212711424 |
|---|---|
| author | Rytlewski, J. Fuller, J. Mertz, D. R. Freeman, C. Manier, S. Shah, N. Campbell, T. B. |
| author_facet | Rytlewski, J. Fuller, J. Mertz, D. R. Freeman, C. Manier, S. Shah, N. Campbell, T. B. |
| author_sort | Rytlewski, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430743 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307432022-08-31 P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) Rytlewski, J. Fuller, J. Mertz, D. R. Freeman, C. Manier, S. Shah, N. Campbell, T. B. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430743/ http://dx.doi.org/10.1097/01.HS9.0000846344.56300.e1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Rytlewski, J. Fuller, J. Mertz, D. R. Freeman, C. Manier, S. Shah, N. Campbell, T. B. P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) |
| title | P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) |
| title_full | P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) |
| title_fullStr | P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) |
| title_full_unstemmed | P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) |
| title_short | P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121) |
| title_sort | p866: correlative analysis to define patient profiles associated with manufacturing and clinical endpoints in relapsed/refractory multiple myeloma patients treated with idecabtagene vicleucel (bb2121) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430743/ http://dx.doi.org/10.1097/01.HS9.0000846344.56300.e1 |
| work_keys_str_mv | AT rytlewskij p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 AT fullerj p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 AT mertzdr p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 AT freemanc p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 AT maniers p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 AT shahn p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 AT campbelltb p866correlativeanalysistodefinepatientprofilesassociatedwithmanufacturingandclinicalendpointsinrelapsedrefractorymultiplemyelomapatientstreatedwithidecabtagenevicleucelbb2121 |